COMMERCIALIZATION SOLUTIONS FOR THE ORTHOPEDIC INDUSTRY
JANUARY 2020 | VOLUME 1

Suppliers and design firms are expanding their capabilities in anticipation of increased customer requests. Experts from NN Life Sciences, Orchid Orthopedic, Primordial Soup and Viant explain why.

New President and CEO Darin Johnson will build on Exactech’s foundation in joint replacement following two strong years of sales and investments in R&D, people and infrastructure.

Companies seeking to address unmet needs may find inspiration in this network of surgeons who have started companies such as JointPoint, Monogram Orthopaedics, Precision OS and Tensor Surgical. 

Acquisitions of Arthrosurface and Parcus Medical significantly bolster the company's product portfolio in addition to providing ample cross-selling opportunities and a call-point to ASCs.
Featured White Paper:

Identify critical considerations for Work-In-Process Exposure vulnerabilities. A disciplined assessment of the contributors to Overall Exposure Risk supports fact-based decisions to yield repeatable, capable processes that reduce device degradation.

FDA is expected to enforce new orthobiologic guidance in 2020. Dr. Scott Bruder argues that companies seeking commercial success would be well-served to abide by FDA guidance and invest in developing high quality indication-specific evidence.
Registration opens February 2020. Booth applications can be completed here .
Speaking Opportunities!
Exhibitors and attendees alike are invited to present technical knowledge, best practices, case studies, how-tos and innovations to enhance the learning and networking opportunities for all participants. Learn how.

Presentation abstracts are due by February 25.
Did you miss it?

Acquisitions, biologics, enabling technology and loss of market share by the big players all made our list. Read the specifics and access our projections for 2019 revenue by company and segment.

JNJ is combining robotics, enhanced visualization, advanced instrumentation, machine learning and wearables as it continues to grow its medical intervention portfolio across a range of applications.

The technology will be introduced as part of DePuy Synthes’ VELYS Digital Surgery solutions.

The company acquired all assets of IntraFuse, including proprietary intramedullary implants for the minimally invasive repair of fibula and other fractures

The system allows anatomic visualization to guide the procedure in real time, as if using x-ray vision.
From the Archives:

Your first step is to candidly discuss three foundational elements for a successful pairing: trust, transparency and compatibility.

Copyright © 2020. All Rights Reserved.